Therapeutic Potential of Resveratrol in COVID-19-Associated Hemostatic Disorders

Year Published: 2021




Roberta Giordo, Angelo Zinellu, Ali Hussein Eid, Gianfranco Pintus


This review looks at the potential of resveratrol to lower COVID-19-associated mortality, potentially through reducing inflammation. Resveratrol is an atnioxidants found in grapes, peanuts, and cranberries.

Key Findings

Key Findings: According to the study, "By virtue of its ability to modulate platelet activation and aggregation as well as factors involved in the coagulation cascade, resveratrol appears to be an attractive pharmacotherapeutic agent in the fight against COVID-19. We speculate that it could serve as an adjunct treatment for slowing and ameliorating phenomena associated with the severe COVID-19 outcomes, such as vascular thrombosis and systemic inflammation. Although a dosage ranging between 30 and 300 mg would appear to maximize resveratrol benefits while minimizing potential side effects, further clinical trials are needed to provide definitive answers in this context."